Lipella Pharmaceuticals Inc.
LIPO- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347242
No open-market purchases or sales by Lipella Pharmaceuticals Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Lipella Pharmaceuticals Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 5 | 3 | −2 |
| Shares | 84.8K | 13.4K | −71.4K (−84.1%) |
| Value | $39.7K | $41.4K | +$1.70K (+4.3%) |
New holders (2)
Institutions that held Lipella Pharmaceuticals Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 13,310 | $41.0K | 0.00% |
| MAI Capital Management | 125 | $382 | 0.00% |
Sold out (4)
Institutions that held Lipella Pharmaceuticals Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Vanguard Group Inc | 34,520 | $16.3K |
| Geode Capital Management, LLC | 24,915 | $11.8K |
| HRT Financial LP | 17,619 | $8.00K |
| Tower Research Capital LLC (TRC) | 7,694 | $3.63K |